Skip to main content

Table 2 Peripheral levels of uric acid, albumin, and total bilirubin in schizophrenic patients in the acute stage and healthy controls

From: Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study

Group

UA (μmol/L)

ALB (g/L)

TBIL (μmol/L)

SCZ-AS(n = 107)

308.29 ± 78.71a*

42.79 ± 3.55a***

18.43 ± 9.00a***

 Male(n = 40)

350.45 ± 66.54

44.02 ± 3.36a***

19.74 ± 10.89 a***

 Female(n = 67)

284.72 ± 75.45 a**

42.05 ± 3.48 a***

17.65 ± 7.65 a***

AU(n = 56)

330.32 ± 81.69 a***,b**

43.13 ± 3.17a***

16.56 ± 5.37a***,b**

ANF(n = 51)

286.19 ± 68.94

42.40 ± 3.92 a***

20.47 ± 11.49 a***

HC(n = 273)

283.41 ± 68.61

48.01 ± 3.28

10.87 ± 5.18

 Male(n = 93)

338.69 ± 52.42

48.93 ± 4.29

12.97 ± 6.24

 Female(n = 180)

254.84 ± 57.72

47.54 ± 2.49

9.78 ± 4.16

  1. *P < 0.05; **P < 0.01; ***P < 0.001
  2. a Compared with the healthy controls group. b Compared with the antipsychotics-naïve/free subgroup. SCZ-AS schizophrenic patients in the acute stage, AU antipsychotics-use, ANF antipsychotics-naïve/free, HC healthy control, UA uric acid, ALB albumin, TBIL total bilirubin